Associated Papers
Mutant p53 as an Antigen in Cancer Immunotherapy.
Sobhani N et al.
International Journal of Molecular Sciences, 2020
Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome.
Amadou A et al.
Current Opinion in Oncology, 2018
Select a paper to view details